Endocrinology Drugs-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Endocrinology Drugs-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Endocrinology Drugs industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Endocrinology Drugs 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Endocrinology Drugs worldwide and market share by regions, with company and product introduction, position in the Endocrinology Drugs market
Market status and development trend of Endocrinology Drugs by types and applications
Cost and profit status of Endocrinology Drugs, and marketing status
Market growth drivers and challenges
The report segments the global Endocrinology Drugs market as:
Global Endocrinology Drugs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Endocrinology Drugs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diabetes mellitus
Hyperthyroidism
Hypothyroidism
Pituitary acromegaly
Prolactinoma
Others
Global Endocrinology Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Thyroid hormone disorder drugs
Diabetes drugs
Human growth hormone
Testosterone replacement therapy
Global Endocrinology Drugs Market: Manufacturers Segment Analysis (Company and Product introduction, Endocrinology Drugs Sales Volume, Revenue, Price and Gross Margin):
Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
AbbVie
Acerus Pharmaceuticals
Acrux DDS
Akros Pharma
Exsulin
Ferring Pharmaceuticals
Gan & Lee Pharmaceuticals
Genentech
Generex
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Endocrinology Drugs-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Endocrinology Drugs industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Endocrinology Drugs 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Endocrinology Drugs worldwide and market share by regions, with company and product introduction, position in the Endocrinology Drugs market
Market status and development trend of Endocrinology Drugs by types and applications
Cost and profit status of Endocrinology Drugs, and marketing status
Market growth drivers and challenges
The report segments the global Endocrinology Drugs market as:
Global Endocrinology Drugs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Endocrinology Drugs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Diabetes mellitus
Hyperthyroidism
Hypothyroidism
Pituitary acromegaly
Prolactinoma
Others
Global Endocrinology Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Thyroid hormone disorder drugs
Diabetes drugs
Human growth hormone
Testosterone replacement therapy
Global Endocrinology Drugs Market: Manufacturers Segment Analysis (Company and Product introduction, Endocrinology Drugs Sales Volume, Revenue, Price and Gross Margin):
Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
AbbVie
Acerus Pharmaceuticals
Acrux DDS
Akros Pharma
Exsulin
Ferring Pharmaceuticals
Gan & Lee Pharmaceuticals
Genentech
Generex
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ENDOCRINOLOGY DRUGS
1.1 Definition of Endocrinology Drugs in This Report
1.2 Commercial Types of Endocrinology Drugs
1.2.1 Diabetes mellitus
1.2.2 Hyperthyroidism
1.2.3 Hypothyroidism
1.2.4 Pituitary acromegaly
1.2.5 Prolactinoma
1.2.6 Others
1.3 Downstream Application of Endocrinology Drugs
1.3.1 Thyroid hormone disorder drugs
1.3.2 Diabetes drugs
1.3.3 Human growth hormone
1.3.4 Testosterone replacement therapy
1.4 Development History of Endocrinology Drugs
1.5 Market Status and Trend of Endocrinology Drugs 2013-2023
1.5.1 Global Endocrinology Drugs Market Status and Trend 2013-2023
1.5.2 Regional Endocrinology Drugs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Endocrinology Drugs 2013-2017
2.2 Sales Market of Endocrinology Drugs by Regions
2.2.1 Sales Volume of Endocrinology Drugs by Regions
2.2.2 Sales Value of Endocrinology Drugs by Regions
2.3 Production Market of Endocrinology Drugs by Regions
2.4 Global Market Forecast of Endocrinology Drugs 2018-2023
2.4.1 Global Market Forecast of Endocrinology Drugs 2018-2023
2.4.2 Market Forecast of Endocrinology Drugs by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Endocrinology Drugs by Types
3.2 Sales Value of Endocrinology Drugs by Types
3.3 Market Forecast of Endocrinology Drugs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Endocrinology Drugs by Downstream Industry
4.2 Global Market Forecast of Endocrinology Drugs by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Endocrinology Drugs Market Status by Countries
5.1.1 North America Endocrinology Drugs Sales by Countries (2013-2017)
5.1.2 North America Endocrinology Drugs Revenue by Countries (2013-2017)
5.1.3 United States Endocrinology Drugs Market Status (2013-2017)
5.1.4 Canada Endocrinology Drugs Market Status (2013-2017)
5.1.5 Mexico Endocrinology Drugs Market Status (2013-2017)
5.2 North America Endocrinology Drugs Market Status by Manufacturers
5.3 North America Endocrinology Drugs Market Status by Type (2013-2017)
5.3.1 North America Endocrinology Drugs Sales by Type (2013-2017)
5.3.2 North America Endocrinology Drugs Revenue by Type (2013-2017)
5.4 North America Endocrinology Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Endocrinology Drugs Market Status by Countries
6.1.1 Europe Endocrinology Drugs Sales by Countries (2013-2017)
6.1.2 Europe Endocrinology Drugs Revenue by Countries (2013-2017)
6.1.3 Germany Endocrinology Drugs Market Status (2013-2017)
6.1.4 UK Endocrinology Drugs Market Status (2013-2017)
6.1.5 France Endocrinology Drugs Market Status (2013-2017)
6.1.6 Italy Endocrinology Drugs Market Status (2013-2017)
6.1.7 Russia Endocrinology Drugs Market Status (2013-2017)
6.1.8 Spain Endocrinology Drugs Market Status (2013-2017)
6.1.9 Benelux Endocrinology Drugs Market Status (2013-2017)
6.2 Europe Endocrinology Drugs Market Status by Manufacturers
6.3 Europe Endocrinology Drugs Market Status by Type (2013-2017)
6.3.1 Europe Endocrinology Drugs Sales by Type (2013-2017)
6.3.2 Europe Endocrinology Drugs Revenue by Type (2013-2017)
6.4 Europe Endocrinology Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Endocrinology Drugs Market Status by Countries
7.1.1 Asia Pacific Endocrinology Drugs Sales by Countries (2013-2017)
7.1.2 Asia Pacific Endocrinology Drugs Revenue by Countries (2013-2017)
7.1.3 China Endocrinology Drugs Market Status (2013-2017)
7.1.4 Japan Endocrinology Drugs Market Status (2013-2017)
7.1.5 India Endocrinology Drugs Market Status (2013-2017)
7.1.6 Southeast Asia Endocrinology Drugs Market Status (2013-2017)
7.1.7 Australia Endocrinology Drugs Market Status (2013-2017)
7.2 Asia Pacific Endocrinology Drugs Market Status by Manufacturers
7.3 Asia Pacific Endocrinology Drugs Market Status by Type (2013-2017)
7.3.1 Asia Pacific Endocrinology Drugs Sales by Type (2013-2017)
7.3.2 Asia Pacific Endocrinology Drugs Revenue by Type (2013-2017)
7.4 Asia Pacific Endocrinology Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Endocrinology Drugs Market Status by Countries
8.1.1 Latin America Endocrinology Drugs Sales by Countries (2013-2017)
8.1.2 Latin America Endocrinology Drugs Revenue by Countries (2013-2017)
8.1.3 Brazil Endocrinology Drugs Market Status (2013-2017)
8.1.4 Argentina Endocrinology Drugs Market Status (2013-2017)
8.1.5 Colombia Endocrinology Drugs Market Status (2013-2017)
8.2 Latin America Endocrinology Drugs Market Status by Manufacturers
8.3 Latin America Endocrinology Drugs Market Status by Type (2013-2017)
8.3.1 Latin America Endocrinology Drugs Sales by Type (2013-2017)
8.3.2 Latin America Endocrinology Drugs Revenue by Type (2013-2017)
8.4 Latin America Endocrinology Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Endocrinology Drugs Market Status by Countries
9.1.1 Middle East and Africa Endocrinology Drugs Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Endocrinology Drugs Revenue by Countries (2013-2017)
9.1.3 Middle East Endocrinology Drugs Market Status (2013-2017)
9.1.4 Africa Endocrinology Drugs Market Status (2013-2017)
9.2 Middle East and Africa Endocrinology Drugs Market Status by Manufacturers
9.3 Middle East and Africa Endocrinology Drugs Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Endocrinology Drugs Sales by Type (2013-2017)
9.3.2 Middle East and Africa Endocrinology Drugs Revenue by Type (2013-2017)
9.4 Middle East and Africa Endocrinology Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ENDOCRINOLOGY DRUGS
10.1 Global Economy Situation and Trend Overview
10.2 Endocrinology Drugs Downstream Industry Situation and Trend Overview
CHAPTER 11 ENDOCRINOLOGY DRUGS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Endocrinology Drugs by Major Manufacturers
11.2 Production Value of Endocrinology Drugs by Major Manufacturers
11.3 Basic Information of Endocrinology Drugs by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Endocrinology Drugs Major Manufacturer
11.3.2 Employees and Revenue Level of Endocrinology Drugs Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ENDOCRINOLOGY DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Novo Nordisk
12.1.1 Company profile
12.1.2 Representative Endocrinology Drugs Product
12.1.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Novo Nordisk
12.2 Sanofi
12.2.1 Company profile
12.2.2 Representative Endocrinology Drugs Product
12.2.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Sanofi
12.3 Merck
12.3.1 Company profile
12.3.2 Representative Endocrinology Drugs Product
12.3.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Merck
12.4 Eli Lily
12.4.1 Company profile
12.4.2 Representative Endocrinology Drugs Product
12.4.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Eli Lily
12.5 AstraZeneca
12.5.1 Company profile
12.5.2 Representative Endocrinology Drugs Product
12.5.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of AstraZeneca
12.6 AbbVie
12.6.1 Company profile
12.6.2 Representative Endocrinology Drugs Product
12.6.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of AbbVie
12.7 Acerus Pharmaceuticals
12.7.1 Company profile
12.7.2 Representative Endocrinology Drugs Product
12.7.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Acerus Pharmaceuticals
12.8 Acrux DDS
12.8.1 Company profile
12.8.2 Representative Endocrinology Drugs Product
12.8.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Acrux DDS
12.9 Akros Pharma
12.9.1 Company profile
12.9.2 Representative Endocrinology Drugs Product
12.9.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Akros Pharma
12.10 Exsulin
12.10.1 Company profile
12.10.2 Representative Endocrinology Drugs Product
12.10.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Exsulin
12.11 Ferring Pharmaceuticals
12.11.1 Company profile
12.11.2 Representative Endocrinology Drugs Product
12.11.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Ferring Pharmaceuticals
12.12 Gan & Lee Pharmaceuticals
12.12.1 Company profile
12.12.2 Representative Endocrinology Drugs Product
12.12.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Gan & Lee Pharmaceuticals
12.13 Genentech
12.13.1 Company profile
12.13.2 Representative Endocrinology Drugs Product
12.13.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Genentech
12.14 Generex
12.14.1 Company profile
12.14.2 Representative Endocrinology Drugs Product
12.14.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Generex
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ENDOCRINOLOGY DRUGS
13.1 Industry Chain of Endocrinology Drugs
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ENDOCRINOLOGY DRUGS
14.1 Cost Structure Analysis of Endocrinology Drugs
14.2 Raw Materials Cost Analysis of Endocrinology Drugs
14.3 Labor Cost Analysis of Endocrinology Drugs
14.4 Manufacturing Expenses Analysis of Endocrinology Drugs
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Endocrinology Drugs in This Report
1.2 Commercial Types of Endocrinology Drugs
1.2.1 Diabetes mellitus
1.2.2 Hyperthyroidism
1.2.3 Hypothyroidism
1.2.4 Pituitary acromegaly
1.2.5 Prolactinoma
1.2.6 Others
1.3 Downstream Application of Endocrinology Drugs
1.3.1 Thyroid hormone disorder drugs
1.3.2 Diabetes drugs
1.3.3 Human growth hormone
1.3.4 Testosterone replacement therapy
1.4 Development History of Endocrinology Drugs
1.5 Market Status and Trend of Endocrinology Drugs 2013-2023
1.5.1 Global Endocrinology Drugs Market Status and Trend 2013-2023
1.5.2 Regional Endocrinology Drugs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Endocrinology Drugs 2013-2017
2.2 Sales Market of Endocrinology Drugs by Regions
2.2.1 Sales Volume of Endocrinology Drugs by Regions
2.2.2 Sales Value of Endocrinology Drugs by Regions
2.3 Production Market of Endocrinology Drugs by Regions
2.4 Global Market Forecast of Endocrinology Drugs 2018-2023
2.4.1 Global Market Forecast of Endocrinology Drugs 2018-2023
2.4.2 Market Forecast of Endocrinology Drugs by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Endocrinology Drugs by Types
3.2 Sales Value of Endocrinology Drugs by Types
3.3 Market Forecast of Endocrinology Drugs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Endocrinology Drugs by Downstream Industry
4.2 Global Market Forecast of Endocrinology Drugs by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Endocrinology Drugs Market Status by Countries
5.1.1 North America Endocrinology Drugs Sales by Countries (2013-2017)
5.1.2 North America Endocrinology Drugs Revenue by Countries (2013-2017)
5.1.3 United States Endocrinology Drugs Market Status (2013-2017)
5.1.4 Canada Endocrinology Drugs Market Status (2013-2017)
5.1.5 Mexico Endocrinology Drugs Market Status (2013-2017)
5.2 North America Endocrinology Drugs Market Status by Manufacturers
5.3 North America Endocrinology Drugs Market Status by Type (2013-2017)
5.3.1 North America Endocrinology Drugs Sales by Type (2013-2017)
5.3.2 North America Endocrinology Drugs Revenue by Type (2013-2017)
5.4 North America Endocrinology Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Endocrinology Drugs Market Status by Countries
6.1.1 Europe Endocrinology Drugs Sales by Countries (2013-2017)
6.1.2 Europe Endocrinology Drugs Revenue by Countries (2013-2017)
6.1.3 Germany Endocrinology Drugs Market Status (2013-2017)
6.1.4 UK Endocrinology Drugs Market Status (2013-2017)
6.1.5 France Endocrinology Drugs Market Status (2013-2017)
6.1.6 Italy Endocrinology Drugs Market Status (2013-2017)
6.1.7 Russia Endocrinology Drugs Market Status (2013-2017)
6.1.8 Spain Endocrinology Drugs Market Status (2013-2017)
6.1.9 Benelux Endocrinology Drugs Market Status (2013-2017)
6.2 Europe Endocrinology Drugs Market Status by Manufacturers
6.3 Europe Endocrinology Drugs Market Status by Type (2013-2017)
6.3.1 Europe Endocrinology Drugs Sales by Type (2013-2017)
6.3.2 Europe Endocrinology Drugs Revenue by Type (2013-2017)
6.4 Europe Endocrinology Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Endocrinology Drugs Market Status by Countries
7.1.1 Asia Pacific Endocrinology Drugs Sales by Countries (2013-2017)
7.1.2 Asia Pacific Endocrinology Drugs Revenue by Countries (2013-2017)
7.1.3 China Endocrinology Drugs Market Status (2013-2017)
7.1.4 Japan Endocrinology Drugs Market Status (2013-2017)
7.1.5 India Endocrinology Drugs Market Status (2013-2017)
7.1.6 Southeast Asia Endocrinology Drugs Market Status (2013-2017)
7.1.7 Australia Endocrinology Drugs Market Status (2013-2017)
7.2 Asia Pacific Endocrinology Drugs Market Status by Manufacturers
7.3 Asia Pacific Endocrinology Drugs Market Status by Type (2013-2017)
7.3.1 Asia Pacific Endocrinology Drugs Sales by Type (2013-2017)
7.3.2 Asia Pacific Endocrinology Drugs Revenue by Type (2013-2017)
7.4 Asia Pacific Endocrinology Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Endocrinology Drugs Market Status by Countries
8.1.1 Latin America Endocrinology Drugs Sales by Countries (2013-2017)
8.1.2 Latin America Endocrinology Drugs Revenue by Countries (2013-2017)
8.1.3 Brazil Endocrinology Drugs Market Status (2013-2017)
8.1.4 Argentina Endocrinology Drugs Market Status (2013-2017)
8.1.5 Colombia Endocrinology Drugs Market Status (2013-2017)
8.2 Latin America Endocrinology Drugs Market Status by Manufacturers
8.3 Latin America Endocrinology Drugs Market Status by Type (2013-2017)
8.3.1 Latin America Endocrinology Drugs Sales by Type (2013-2017)
8.3.2 Latin America Endocrinology Drugs Revenue by Type (2013-2017)
8.4 Latin America Endocrinology Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Endocrinology Drugs Market Status by Countries
9.1.1 Middle East and Africa Endocrinology Drugs Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Endocrinology Drugs Revenue by Countries (2013-2017)
9.1.3 Middle East Endocrinology Drugs Market Status (2013-2017)
9.1.4 Africa Endocrinology Drugs Market Status (2013-2017)
9.2 Middle East and Africa Endocrinology Drugs Market Status by Manufacturers
9.3 Middle East and Africa Endocrinology Drugs Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Endocrinology Drugs Sales by Type (2013-2017)
9.3.2 Middle East and Africa Endocrinology Drugs Revenue by Type (2013-2017)
9.4 Middle East and Africa Endocrinology Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ENDOCRINOLOGY DRUGS
10.1 Global Economy Situation and Trend Overview
10.2 Endocrinology Drugs Downstream Industry Situation and Trend Overview
CHAPTER 11 ENDOCRINOLOGY DRUGS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Endocrinology Drugs by Major Manufacturers
11.2 Production Value of Endocrinology Drugs by Major Manufacturers
11.3 Basic Information of Endocrinology Drugs by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Endocrinology Drugs Major Manufacturer
11.3.2 Employees and Revenue Level of Endocrinology Drugs Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ENDOCRINOLOGY DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Novo Nordisk
12.1.1 Company profile
12.1.2 Representative Endocrinology Drugs Product
12.1.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Novo Nordisk
12.2 Sanofi
12.2.1 Company profile
12.2.2 Representative Endocrinology Drugs Product
12.2.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Sanofi
12.3 Merck
12.3.1 Company profile
12.3.2 Representative Endocrinology Drugs Product
12.3.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Merck
12.4 Eli Lily
12.4.1 Company profile
12.4.2 Representative Endocrinology Drugs Product
12.4.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Eli Lily
12.5 AstraZeneca
12.5.1 Company profile
12.5.2 Representative Endocrinology Drugs Product
12.5.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of AstraZeneca
12.6 AbbVie
12.6.1 Company profile
12.6.2 Representative Endocrinology Drugs Product
12.6.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of AbbVie
12.7 Acerus Pharmaceuticals
12.7.1 Company profile
12.7.2 Representative Endocrinology Drugs Product
12.7.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Acerus Pharmaceuticals
12.8 Acrux DDS
12.8.1 Company profile
12.8.2 Representative Endocrinology Drugs Product
12.8.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Acrux DDS
12.9 Akros Pharma
12.9.1 Company profile
12.9.2 Representative Endocrinology Drugs Product
12.9.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Akros Pharma
12.10 Exsulin
12.10.1 Company profile
12.10.2 Representative Endocrinology Drugs Product
12.10.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Exsulin
12.11 Ferring Pharmaceuticals
12.11.1 Company profile
12.11.2 Representative Endocrinology Drugs Product
12.11.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Ferring Pharmaceuticals
12.12 Gan & Lee Pharmaceuticals
12.12.1 Company profile
12.12.2 Representative Endocrinology Drugs Product
12.12.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Gan & Lee Pharmaceuticals
12.13 Genentech
12.13.1 Company profile
12.13.2 Representative Endocrinology Drugs Product
12.13.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Genentech
12.14 Generex
12.14.1 Company profile
12.14.2 Representative Endocrinology Drugs Product
12.14.3 Endocrinology Drugs Sales, Revenue, Price and Gross Margin of Generex
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ENDOCRINOLOGY DRUGS
13.1 Industry Chain of Endocrinology Drugs
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ENDOCRINOLOGY DRUGS
14.1 Cost Structure Analysis of Endocrinology Drugs
14.2 Raw Materials Cost Analysis of Endocrinology Drugs
14.3 Labor Cost Analysis of Endocrinology Drugs
14.4 Manufacturing Expenses Analysis of Endocrinology Drugs
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
